Moderate riskFDA DrugClass II

Mylan mycophenolate mofetil injection recalled for precipitate

Mylan Pharmaceuticals is recalling one lot of mycophenolate mofetil for injection vials because of the presence of precipitate, which is solid material that has separated out of the liquid. The recall covers 5,688 single-dose vials distributed nationwide. No injuries have been reported.

From the FDA notice · Read the official notice ↗ · All Mylan recalls

What to do

  1. Talk to your pharmacist or prescriber before stopping this medicine.
  2. Check whether the vial is lot 3241653 with expiration date 4/30/2027, or whether the carton is NDC 67457-386-81 (vial NDC 67457-386-00).
  3. The notice doesn't say how to get a refund or replacement; contact Mylan Pharmaceuticals or where you bought it.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV, 26505 USA, Made in India, NDC 67457-386-00 (vial label) & NDC 67457-386-81 (carton label).
Sold in
Nationwide
Made for
All ages (0 months and older)

Details

Units affected
5688 vials
Illnesses reported
None reported
Manufactured in
1311 Pineview Dr, N/A, Morgantown, WV, United States
Classification
Class II
Recall number
D-0734-2026

In the FDA's words

Description
Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV, 26505 USA, Made in India, NDC 67457-386-00 (vial label) & NDC 67457-386-81 (carton label). Presence of precipitate Lot #: 3241653, Exp 4/30/2027 Distribution: USA Nationwide Affected quantity: 5688 vials
Hazard
Presence of precipitate

More from Mylan

See all

Related topics

ParticulateDrugsSold nationwideMore from FDA Drug